Literature DB >> 26656117

Contrasting Adult and Infant Immune Responses to HIV Infection and Vaccination.

David R Martinez1, Sallie R Permar2, Genevieve G Fouda3.   

Abstract

Extensive studies have demonstrated that infant immune responses are distinct from those of adults. Despite these differences, infant immunization can elicit protective immune responses at levels comparable to or, in some cases, higher than adult immune responses to many vaccines. To date, only a few HIV vaccine candidates have been tested in infant populations, and none of them evaluated vaccine efficacy. Recent exciting studies showing that HIV-infected infants can develop broad neutralizing antibody responses and that some HIV vaccine regimens can elicit high levels of potentially protective antibodies in infants provide support for the development and testing of HIV vaccines in pediatric populations. In this review, we discuss the differences in adult and infant immune responses in the setting of HIV infection and vaccination.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26656117      PMCID: PMC4744916          DOI: 10.1128/CVI.00565-15

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  101 in total

1.  CpG drives human transitional B cells to terminal differentiation and production of natural antibodies.

Authors:  Federica Capolunghi; Simona Cascioli; Ezio Giorda; Maria Manuela Rosado; Alessandro Plebani; Cinzia Auriti; Giulio Seganti; Roberta Zuntini; Simona Ferrari; Maria Cagliuso; Isabella Quinti; Rita Carsetti
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

2.  Independent evolution of Fc- and Fab-mediated HIV-1-specific antiviral antibody activity following acute infection.

Authors:  Anne-Sophie Dugast; Leonidas Stamatatos; Andrew Tonelli; Todd J Suscovich; Anna F Licht; Iliyana Mikell; Margaret E Ackerman; Hendrik Streeck; P J Klasse; John P Moore; Galit Alter
Journal:  Eur J Immunol       Date:  2014-08-11       Impact factor: 5.532

3.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

4.  Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies.

Authors:  Michael Vaine; Shixia Wang; Qin Liu; James Arthos; David Montefiori; Paul Goepfert; M Juliana McElrath; Shan Lu
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

5.  Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals.

Authors:  Johannes F Scheid; Hugo Mouquet; Niklas Feldhahn; Michael S Seaman; Klara Velinzon; John Pietzsch; Rene G Ott; Robert M Anthony; Henry Zebroski; Arlene Hurley; Adhuna Phogat; Bimal Chakrabarti; Yuxing Li; Mark Connors; Florencia Pereyra; Bruce D Walker; Hedda Wardemann; David Ho; Richard T Wyatt; John R Mascola; Jeffrey V Ravetch; Michel C Nussenzweig
Journal:  Nature       Date:  2009-03-15       Impact factor: 49.962

6.  Detection of HIV-specific cell-mediated cytotoxicity in the peripheral blood from infected children.

Authors:  F Buseyne; S Blanche; D Schmitt; C Griscelli; Y Rivière
Journal:  J Immunol       Date:  1993-04-15       Impact factor: 5.422

7.  Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines.

Authors:  Amy W Chung; Musie Ghebremichael; Hannah Robinson; Eric Brown; Ickwon Choi; Sophie Lane; Anne-Sophie Dugast; Matthew K Schoen; Morgane Rolland; Todd J Suscovich; Alison E Mahan; Larry Liao; Hendrik Streeck; Charla Andrews; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Mark S de Souza; Jaranit Kaewkungwal; Punnee Pitisuttithum; Donald Francis; Nelson L Michael; Jerome H Kim; Chris Bailey-Kellogg; Margaret E Ackerman; Galit Alter
Journal:  Sci Transl Med       Date:  2014-03-19       Impact factor: 17.956

8.  Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination.

Authors:  Nicole L Yates; Hua-Xin Liao; Youyi Fong; Allan deCamp; Nathan A Vandergrift; William T Williams; S Munir Alam; Guido Ferrari; Zhi-yong Yang; Kelly E Seaton; Phillip W Berman; Michael D Alpert; David T Evans; Robert J O'Connell; Donald Francis; Faruk Sinangil; Carter Lee; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Punnee Pitisuttithum; James Tartaglia; Abraham Pinter; Susan Zolla-Pazner; Peter B Gilbert; Gary J Nabel; Nelson L Michael; Jerome H Kim; David C Montefiori; Barton F Haynes; Georgia D Tomaras
Journal:  Sci Transl Med       Date:  2014-03-19       Impact factor: 17.956

9.  Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials.

Authors:  David C Montefiori; Chitraporn Karnasuta; Ying Huang; Hasan Ahmed; Peter Gilbert; Mark S de Souza; Robert McLinden; Sodsai Tovanabutra; Agnes Laurence-Chenine; Eric Sanders-Buell; M Anthony Moody; Mattia Bonsignori; Christina Ochsenbauer; John Kappes; Haili Tang; Kelli Greene; Hongmei Gao; Celia C LaBranche; Charla Andrews; Victoria R Polonis; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Steve G Self; Phillip W Berman; Donald Francis; Faruk Sinangil; Carter Lee; Jim Tartaglia; Merlin L Robb; Barton F Haynes; Nelson L Michael; Jerome H Kim
Journal:  J Infect Dis       Date:  2012-05-25       Impact factor: 5.226

10.  Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses.

Authors:  Genevieve G Fouda; Coleen K Cunningham; Elizabeth J McFarland; William Borkowsky; Petronella Muresan; Justin Pollara; Lin Ye Song; Brooke E Liebl; Kaylan Whitaker; Xiaoying Shen; Nathan A Vandergrift; R Glenn Overman; Nicole L Yates; M Anthony Moody; Carrie Fry; Jerome H Kim; Nelson L Michael; Merlin Robb; Punnee Pitisuttithum; Jaranit Kaewkungwal; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Hua-Xin Liao; Barton F Haynes; David C Montefiori; Guido Ferrari; Georgia D Tomaras; Sallie R Permar
Journal:  J Infect Dis       Date:  2014-08-27       Impact factor: 7.759

View more
  21 in total

1.  Differences in inducibility of the latent HIV reservoir in perinatal and adult infection.

Authors:  Adit Dhummakupt; Jessica H Rubens; Thuy Anderson; Laura Powell; Bareng As Nonyane; Lilly V Siems; Aleisha Collinson-Streng; Tricia Nilles; R Brad Jones; Vicki Tepper; Allison Agwu; Deborah Persaud
Journal:  JCI Insight       Date:  2020-02-27

Review 2.  The HIV-1 antibody response: a footprint of the viral reservoir in children vertically infected with HIV.

Authors:  Paolo Palma; Margaret McManus; Nicola Cotugno; Salvatore Rocca; Paolo Rossi; Katherine Luzuriaga
Journal:  Lancet HIV       Date:  2020-05       Impact factor: 12.767

Review 3.  Cross-reactivity of HIV vaccine responses and the microbiome.

Authors:  Wilton B Williams; Qifeng Han; Barton F Haynes
Journal:  Curr Opin HIV AIDS       Date:  2018-01       Impact factor: 4.283

4.  Infant/child rapid serology tests fail to reliably assess HIV exposure among sick hospitalized infants.

Authors:  Anjuli D Wagner; Irene N Njuguna; Ruth A Andere; Lisa M Cranmer; Helen M Okinyi; Sarah Benki-Nugent; Bhavna H Chohan; Elizabeth Maleche-Obimbo; Dalton C Wamalwa; Grace C John-Stewart
Journal:  AIDS       Date:  2017-07-17       Impact factor: 4.177

5.  Simian-Human Immunodeficiency Virus SHIV.CH505-Infected Infant and Adult Rhesus Macaques Exhibit Similar Env-Specific Antibody Kinetics, despite Distinct T-Follicular Helper and Germinal Center B Cell Landscapes.

Authors:  Ashley N Nelson; Ria Goswami; Maria Dennis; Joshua Tu; Riley J Mangan; Pooja T Saha; Derek W Cain; Alan D Curtis; Xiaoying Shen; George M Shaw; Katharine Bar; Michael Hudgens; Justin Pollara; Kristina De Paris; Koen K A Van Rompay; Sallie R Permar
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

6.  HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine.

Authors:  Sallie R Permar; Genevieve G Fouda; Erin P McGuire; Youyi Fong; Christopher Toote; Coleen K Cunningham; Elizabeth J McFarland; William Borkowsky; Susan Barnett; Hannah L Itell; Amit Kumar; Glenda Gray; M Julianna McElrath; Georgia D Tomaras
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

7.  Pattern and Frequency of Seroreactivity to Routinely Used Serologic Tests in Early-Treated Infants With HIV.

Authors:  Thanyawee Puthanakit; Jintanat Ananworanich; Siriwat Akapirat; Supanit Pattanachaiwit; Sasiwimol Ubolyam; Vatcharain Assawadarachai; Panadda Sawangsinth; Thidarat Jupimai; Suvaporn Anugulruengkitt; Monta Tawan; Pope Kosalaraksa; Thitiporn Borkird; Piyarat Suntarattiwong; Suparat Kanjanavanit; Mark S de Souza
Journal:  J Acquir Immune Defic Syndr       Date:  2020-03-01       Impact factor: 3.771

8.  Aging increases the systemic molecular degree of inflammatory perturbation in patients with tuberculosis.

Authors:  Deivide Oliveira-de-Souza; Caian L Vinhaes; María B Arriaga; Nathella Pavan Kumar; Artur T L Queiroz; Kiyoshi F Fukutani; Subash Babu; Bruno B Andrade
Journal:  Sci Rep       Date:  2020-07-09       Impact factor: 4.379

9.  Neonatal Rhesus Macaques Have Distinct Immune Cell Transcriptional Profiles following HIV Envelope Immunization.

Authors:  Qifeng Han; Todd Bradley; Wilton B Williams; Derek W Cain; David C Montefiori; Kevin O Saunders; Robert J Parks; Regina W Edwards; Guido Ferrari; Olaf Mueller; Xiaoying Shen; Kevin J Wiehe; Steven Reed; Christopher B Fox; Wes Rountree; Nathan A Vandergrift; Yunfei Wang; Laura L Sutherland; Sampa Santra; M Anthony Moody; Sallie R Permar; Georgia D Tomaras; Mark G Lewis; Koen K A Van Rompay; Barton F Haynes
Journal:  Cell Rep       Date:  2020-02-04       Impact factor: 9.423

10.  IL-8 Alterations in HIV-1 Infected Children With Disease Progression.

Authors:  Ambili Nair Pananghat; Heena Aggarwal; Somi Sankaran Prakash; Muzamil Ashraf Makhdoomi; Ravinder Singh; Rakesh Lodha; Shakir Ali; Maddur Srinivas; Bimal Kumar Das; Ravindra Mohan Pandey; Sushil Kumar Kabra; Kalpana Luthra
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.